Skip to main content
. Author manuscript; available in PMC: 2018 Mar 14.
Published in final edited form as: Circulation. 2016 Dec 27;135(11):1011–1020. doi: 10.1161/CIRCULATIONAHA.116.024421

Figure 2. Expression of fibrinolytic inhibitors at the site of pulmonary emboli.

Figure 2

Lung tissue containing FITC-fibrin labeled (green) pulmonary emboli was immunostained (red) to detect the expression of (A) α2-antiplasmin (a2AP) and (B) PAI-1. (C) The total immune-stained area (arbitrary units; a.u) for each protein was measured in a 20× (100 μm) image of embolized vs non-embolized (control; outlined yellow) pulmonary artery in the lungs. n=3, mean ± SEM. **p<0.01; ns, non-significant.